uniQure (QURE) Cash from Financing Activities (2016 - 2026)

uniQure's (QURE) quarterly Cash from Financing Activities came in at $550000.0 in Q1 2026, down 99.32% year-on-year from $80.7 million in Q1 2025, and down 77.54% quarter-over-quarter from $2.4 million in Q4 2025.

uniQure (QURE) Cash from Financing Activities (2016 - 2026) Analysis & Trends

uniQure's Cash from Financing Activities history runs 11 years deep, the most recent figure standing at $550000.0 for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities fell 99.32% year-over-year to $550000.0 in Q1 2026; TTM through Mar 2026 was $335.3 million, a 1482.99% increase from a year earlier, with the FY2025 full-year figure at $415.4 million, up 798.31% from the prior year.
  • Cash from Financing Activities slipped to $550000.0 in Q1 2026 per QURE's latest filing, from $2.4 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $370.1 million in Q2 2023 and bottomed at -$53.0 million in Q3 2024.
  • The 5-year median for Cash from Financing Activities is $301000.0 (2022), against an average of $48.0 million.
  • Across the five-year window, Cash from Financing Activities jumped 638067.24% in 2023 and sank 14267.39% in 2024, its largest moves.
  • Year by year, Cash from Financing Activities stood at $601000.0 in 2022, then slumped by 92.35% to $46000.0 in 2023, then sank by 14267.39% to -$6.5 million in 2024, then surged by 137.58% to $2.4 million in 2025, then slumped by 77.54% to $550000.0 in 2026.
  • Per Business Quant, the three latest QURE Cash from Financing Activities figures stand at $550000.0 (Q1 2026), $2.4 million (Q4 2025), and $332.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 30.14 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 68.63 Mn
4 NuCana 279.75 Bn 279.75 Bn - 9,311.16
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -538.80 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -802.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 238.74 Mn
10 uniQure 2.47 Bn 2.47 Bn 3.34 Mn 550,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 550,000.00
Mar 31, 2026 550,000.00
Dec 31, 2025 2.45 Mn
Dec 31, 2025 2.45 Mn
Sep 30, 2025 332.24 Mn
Sep 30, 2025 332.24 Mn
Jun 30, 2025 44,000.00
Jun 30, 2025 44,000.00
Mar 31, 2025 80.67 Mn
Mar 31, 2025 80.67 Mn
Dec 31, 2024 -6.52 Mn
Dec 31, 2024 -6.52 Mn
Sep 30, 2024 -53.02 Mn
Sep 30, 2024 -53.02 Mn
Dec 31, 2023 46,000.00
Dec 31, 2023 46,000.00
Sep 30, 2023 -7.59 Mn
Sep 30, 2023 -7.59 Mn
Jun 30, 2023 370.14 Mn
Jun 30, 2023 370.14 Mn